
Arrowhead’s Second Annual Drug Delivery Summit is being organized to provide an integral forum for a critical examination of and discussion of the trends and issues facing the drug delivery industry today. This conference will provide you with thoughful insight from key industry leaders concerning cutting edge drug delivery technology, as well as new trends in successful drug delivery deal structuring and licensing.
The conference will include case studies of successes and failures in the industry as well as a special focus on the role of drug delivery in successful product lifecycle management. The conference will also explore new and innovative technologies that are meeting the challenges of biologic drug delivery.
For more infomation about this conference, please contact us. To enquire about sponsorship and/or exhibiting at this conference please e-mail marketing@arrowheadpublishers.com.
2nd Annual Drug Delivery Summit
New Technologies and Commercialization Trends
May 1-2, 2008 — San Francisco, California
![]() online event registration by RegOnline |
Early Bird Pricing (before March 20th)
Conference: $1395
Conference + Workshop: $1695
Workshop only: $395
Regular Pricing
Conference: $1495
Conference + Workshop: $1795
Workshop only: $495
Academic, Government and Non-Profit Pricing
Conference: $995
Conference + Workshop: $1145
Workshop only: $245
Group Discounts
For every three paid registrations, get a fourth FREE. Please call (866) 397-1376 or (312) 244-3703 to take advantage of this offer.
Substitution/Cancellation Policy
Your registration may be transferred to a member of your organization up to 24 hours in advance of the conference.
Please fax or mail notice of cancellation to:
Arrowhead Publishers
314 Clifton Avenue, Suite 201
Minneapolis, MN 55403
(866) 397-1376 or (312) 244-3703
Arrowhead Conferences bring together thought leaders and high-level executives from throughout the biotech and pharmaceutical industries. Our conferences tackle the issues and trends that are shaping the future of healthcare, including advances in drug discovery, clinical development, strategic alliances, new technologies and business development.
Arrowhead can design tailor-made sponsorship and/or exhibitor packages that can help grow your businesses through direct and targeted exposure to industry leaders and decision makers.
To gain critical exposure via sponsorship and exhibiting opportunities, please contact us or call (312) 244-3703.
Arrowhead Conferences is looking for media partners for individual conferences as well as long-term partnerships for multiple events.
Gain exposure to high-level executives via Arrowhead’s biotech and pharmaceutical conferences. A range of exchanges are available through our Media partnerships.
Please contact us at marketing@arrowheadpublishers.com or call us at (312) 244-3703 to discuss opportunities available to your company.
Your source for market research and business intelligence products for the pharmaceutical, biotechnology and healthcare industries. Market Report Source is a web portal for market research and business intelligence publications about the global biotechnology, healthcare and pharmaceutical industries. Market is the only US-based web portal that caters exclusively to the needs of the life sciences industry.
PharmaCircle database is a one stop shop for global pharma/bio, specialty pharma and drug delivery related technical as well as business information and analysis. PharmaCircle extracts every possible pipeline/product, technology and molecule specific information, deal financials, sales and royalties from press releases and financial documents. Extensive search options put every possible information for products, molecules and technologies at your fingertips as graphs and tables.
ONdrugDelivery is rapidly establishing itself as a leading provider of niche industry information on the drug delivery sector. Publisher of a series of technology-specific sponsored publications, ONdrugDelivery is a specialist, with focused coverage of drug delivery and a global reach. What could ONdrugDelivery do for you?
Pharmalicensing is the world’s number one biopharmaceutical partnering resource, for executives involved with partnering, licensing and business development. Actively supporting in- and out-licensing activity, Pharmalicensing.com is visited by over 50, 000 visitors each month.
A subscription to Partnering tools provides instant access to comprehensive information, including a company directory with over 6,000 new and established companies, deals review and categorized news services. Pharmalicensing’s business development reports provide key business intelligence to biopharma dealmakers.
PharmiWeb Solutions is an award winning portal operator and e-business solutions provider delivering real benefit to pharmaceutical, biotech and healthcare organisations through enhanced customer reach, increased sales revenue and lower operating costs.
PharmaVOICE magazine, and its supporting VIEW publications, provide readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 17,500 U.S.-based subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
Learn how experienced licensing executives get their deals done, both in-licensing and out-licensing. Going beyond platitudes to pearls gleaned from over a decade of licensing, our workshop host brings his experience and those of others to offer practical tips to getting deals done. Whether your needs are for in-licensing, out-licensing, acquisition or divestiture, or shared collaboration, we will look at the key aspects of must be done to reach a successful transaction.
Get the benefits from do’s and don’ts in:
About Your Workshop leader:
Allen Downs is currently Senior Executive Director, Licensing and Business Development at Purdue Pharma L.P., Allen has responsibility for licensing products and technologies in support of Purdue’s strategic priorities for its pain management business.
Allen has led teams that completed a biotech acquisition, a product co-development alliance, and several in-bound and out-bound licenses. Allen joined Purdue in 1998 after a 10-year career with Bristol-Myers Squibb where he drove international expansion and licensing initiatives for several therapeutic areas.